Observing Genetic Allergy and Immune Dysregulation Disorders Over Time
Follows people with suspected genetic allergic inflammation or immune dysregulation through health records and samples.
Key facts
- Who runs it
- Columbia University
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Allergy and Immunology Natural History Study
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 16 Jul 2010
- Expected to end
- Jan 2027
- Type of study
- Observational
- Record updated
- 4 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people, from birth to 99 years old, who have or may have an inherited disorder of allergic inflammation, mast cell function or immune dysregulation. Blood relatives of these people can also join.
- Age
- From birth to 99 years old.
- Sex
- All sexes can join.
- Disease stage
- A known or suspected inherited disorder of allergic inflammation, mast cell homeostasis or activation, or immune dysregulation.
Main reasons for not taking part
- An acquired immune system problem, such as cytotoxic chemotherapy or malignancy, may be a reason to exclude you if the investigator thinks it would interfere with the evaluation.
- People who cannot or will not give informed consent (or whose guardians cannot or will not) cannot join.
- People who do not agree to have their blood stored for future studies cannot join.
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Subjects, ages birth to 99 years old, known to have or suspected of having an inherited disorder of allergic inflammation, or mast cell homeostasis, or activation or immune dysregulation
- Blood relatives of enrolled subjects will be eligible for enrollment
- There will be no discrimination as to age, gender, race, or disability
- Subjects/guardians must be willing and able to give informed consent
- Subjects must agree to have their blood stored for future studies of the immune system and/or other medical conditions
Who cannot take part
- The presence of an acquired abnormality of the immune system, such as cytotoxic chemotherapy or malignancy may be grounds for possible exclusion if, in the opinion of the investigator, the presence of such a disease process would interfere with evaluation
Where in United States
- Columbia University Irving Medical Center / NewYork-Presbyterian HospitalNew York, United StatesContact: Yannett FranklinTaking people
About the trial
What the trial wants to find out
This protocol is a natural history study designed to evaluate subjects (and some family members) with suspected or identified genetic diseases of allergic inflammation or Immune Dysregulation. Patients determined by clinical history and outside evaluations to be of interest will be consented and enrolled into this study. Blood specimens, stored blood products and derivatives, saliva, hair, fingernail clippings, cord blood, umbilical cord, bone marrow, tissue biopsies and/or buccal swabs from such patients and/or their family members will be obtained for research studies related to understanding genetic and immunopathogenic bases of these diseases. Outside medical records may be obtained, and patient evaluations may be performed to correlate to research laboratory testing results.
The group in the trial
- Inherited diseases of allergic inflammation or immune dysregulation
Patients and blood relatives with disorders of allergic inflammation and immune dysregulation.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Natural History Study for Genetic Diseases of Allergic Inflammation and Immune Dysregulation
- Plain-language title
- Observing Genetic Allergy and Immune Dysregulation Disorders Over TimeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 4 February 2026